By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Developing treatments for inflammatory diseases, with an initial focus on severe respiratory1.03M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Japan2.85M100.00%